Pathology and molecular genetics of the pituitary gland in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (carney complex) 1

Frontiers of Hormone Research

Volumn 32, Issue , 2004, Pages 253-264

  Stratakis, Constantine A ^a   Matyakhina, Ludmila ^a   Courkoutsakis, Nickolas ^a,b   Patronas, Nickolas ^b   Voutetakis, Antonios ^a   Stergiopoulos, Sotirios ^a   Bossis, Ioannis ^a   Aidan Carney, J ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PRKAR1A PROTEIN, HUMAN; PROTEIN;

ENDOCRINE DISEASE; GENETICS; HUMAN; HYPOPHYSIS TUMOR; LENTIGO; MULTIPLE ENDOCRINE NEOPLASIA; MUTATION; MYXOMA; NEURILEMOMA; PATHOLOGY; PIGMENT DISORDER; REVIEW; SKIN PIGMENTATION; SYNDROME;

CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOCRINE SYSTEM DISEASES; GERM-LINE MUTATION; HUMANS; LENTIGO; MULTIPLE ENDOCRINE NEOPLASIA; MYXOMA; NEURILEMMOMA; PIGMENTATION DISORDERS; PITUITARY NEOPLASMS; PROTEINS; SKIN PIGMENTATION; SYNDROME;

EID: 4043073597     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (45)

1. Carney JA, Young WF: Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992;2:6-21.
2. Stratakis CA: The familial lentiginosis syndromes are emerging from the obscurity imposed by rarity: New genes and genetic loci for multiple tumors and developmental defects. Horm Metabol Res 1998;30:285-290.
3. Carney JA: Carney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity and schwannomas. Semin Dermatol 1995;14:90-98.
4. Stratakis CA, Kirschner LS, Carney JA: Carney complex: Diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas. Am J Med Genet 1998;80:183-185.
5. Carney JA, Hruska LS, Beauchamp GD, Gordon H: Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clin Proc 1986;61:165-172.
6. Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, et al: Carney complex, a familial multiple neoplasia and lentiginosis syndrome: Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996;97:699-705.
7. Casey M, Mah C, Merliss AD, Kirschner LS, Taymans SE, Denio AE, et al: Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 1998;98:2560-2566.
8. Stratakis CA, Kirschner LS, Taymans SE, Carney JA, Basson CT: Genetic heterogeneity in Carney complex (OMIM 160980): Contributions of loci at chromosomes 2 and 17 in its genetics. Am J Hum Genet 1999;65(suppl):A447.
9. Stratakis CA, Kirschner LS, Papanicolaou DA, Sarlis NJ, Raff S, Veldhuis JD, et al: Familial acromegaly beyond MEN-1: Genetic and clinical studies in non-GHRH dependent somatomammotroph hyperplasia in patients with Carney complex or an inherited chromosome 11 inversion. 80th Annual Meeting of the Endocrine Society, New Orleans, La, June 1998, P3-552.
10. Raff SB, Carney JA, Krugman D, Doppman JL, Stratakis CA: Prolactin abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and skin myxomas (Carney complex). J Pediatr Endocrinol Metab 2000;13:373-379.
11. Watson JC, Stratakis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, et al: The neurosurgical implications of Carney complex. J Neurosurg 2000;92:413-418.
12. Irvine AD, Armstrong DK, Bingham EA, Hadden DR, Nevin NC, Hughes AE: Evidence for a second genetic locus in Carney complex. Br J Dermatol 1998;139:572-576.
13. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM: Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688-1695.
14. Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, et al: Growth hormoneprolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs_ protein. J Clin Endocrinol Metab 1994;79:1128-1134.
15. Garcia MB, Koppeschaar HIP, Lips CJ, Thijsen JH, Krenning EP: Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: Dynamic endocrine studies and treatment with the somatostatin analogue octreotide. J Endocrinol Invest 1994;17:59-65.
16. Cuttler L, Jackson JA, Uz-Zafar S, Levitsky LL, Mellinger RC, Frohman LA: Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 1989;68:1148-1154.
17. Stratakis CA, Jenkins RB, Pras E, Mitsiadis CS, Raff SB, Stalboerger PG, et al: Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex). J Clin Endocrinol Metab 1996;81:3607-3614.
18. DeMarco L, Stratakis CA, Boson WL, Yakbovitz O, Carson E, Adrade LM, et al: Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gs_ gene. Hum Genet 1996;98:185-188.
19. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA: Mutations of the gene encoding the protein kinase A type I-_ regulatory subunit in patients with the Carney complex. Nat Genet 2000;26:89-92.
20. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA: Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000;9:3037-3046.
21. Stratakis CA, Kirschner LS, Carney JA: Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001;86:4041-4046.
22. Stergiopoulos S, Stratakis CA: Human tumors associated with Carney complex and germline PRKAR1A mutations: A protein kinase A disease! FEBS Lett 2003;546:59-64.
23. Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J: Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD)reveals novel mutations and clues for pathophysiology: Augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet 2002;71:1433-1442.
24. Cho-Chung Y: cAMP signaling in cancer genesis and treatment. Cancer Treat Res 2003;115:123-143.
25. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA: Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex). J Clin Endocrinol Metab 2000;85:3860-3865.
26. Kurtkaya-Yapicier O, Scheithauer BW, Carney JA, Kovacs K, Horvath E, Stratakis CA, Vidal S, Vella A, Young WF Jr, Atkinson JL, Lloyd RV, Kontogeorgos G: Pituitary adenoma in Carney complex: An immunohistochemical, ultrastructural and immunoelectron microscopic study. Ultrastruct Pathol 2002;26:345-353.
27. Ogo A, Haji M, Natori S, Kanzaki T, Kabayama Y, Osamura RY, et al: Acromegaly with hyperprolactinemia developed after bilateral adrenalectomy in a patient with Cushing's syndrome due to adrenocortical nodular hyperplasia. Endocr J 1993;40:17-25.
28. Asa SL, Ezzat S: The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998;19:798-827.
29. Farrell WE, Clayton RN: Epigenetic change in pituitary tumorigenesis. Endocr Relat Cancer 2003;10:323-330.
30. Shintani Y, Yoshimoto K, Horie H, Sano T, Kanesaki Y, Hosoi E, et al: Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormonereleasing hormone-producing pancreatic tumor: Clinical and genetic features. Endocr J 1995;42:331-340.
31. Stratakis CA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA, Shawker T: Thyroid gland abnormalities in patients with the 'syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity'. J Clin Endocrinol Metab 1997;82:2037-2043.
32. Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, et al: Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med 1999;131:585-591.
33. Kovacs K, Horvath E, Thomer MO, Rogol AD: Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virchows Arch Pathol Anat 1984;403:77-86.
34. Feuillan PP, Jones J, Ross JL: Growth hormone hypersecretion in a girl with McCune-Albright syndrome: Comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 1995;80:1357-1360.
35. Sano T, Asa SL, Kovacs K: Growth hormone-releasing hormone-producing tumors: Clinical, biochemical and morphological manifestations. Endocr Rev 1988;9:357-373.
36. Ezzat S, Asa SL, Stefaneanu L, Whittom R, Smyth HS, Horvath E, et al: Somatotroph hyperplasia without pituitary adenoma associated with a long-standing growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 1994;78:555-560.
37. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN: Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 1993;91:2815-2821.
38. Kytola S, Makinen MJ, Kahkonen M, Teh BT, Leisti J, Salmela P: Comparative genomic hybridization studies in tumours from a patient with multiple endocrine neoplasia type 1. Eur J Endocrinol 1998;139:202-206.
39. Cho KR, Vogelstein B: Genetic alterations in the adenoma-carcinoma sequence. Cancer 1992;70:1727-1731.
40. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 1993;4:138-141.
41. Knudson AG: Hereditary cancer: Two hits revisited. J Cancer Res Clin Oncol 1996;122:135-140.
42. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrell WE, Clayton RN, Groussin L, Bertherat J, Stratakis CA: PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 2002;39:e78.
43. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M, Grossman AB: Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) 2002;57:443-448.
44. Yamasaki H, Mizusawa N, Nagahiro S, Yamada S, Sano T, Itakura M, Yoshimoto K: GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clin Endocrinol (Oxf) 2003;58:464-470.
45. Asa SL, Somers K, Ezzat S: The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 1998;83:3210-3212.